Anagenics Ltd has released a press release.
Midkine Antibody Licensing Deal
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Organisational Changes
- H1 FY24 Results and Corporate Update
- Appendix 4D and Half Year Report
- Investor Presentation
Later from Anagenics
- Appendix 4C Cash Flow & Activities Report
- Company Update License Partnership Announcement
- Appendix 4E and Preliminary Final Report
- FY24 4E Presentation
- Pause in Trading
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics